Cargando…
Early recurrence of ischaemic stroke of cardioembolic cause and delayed anticoagulation: a case report
INTRODUCTION: Anticoagulation therapy is used for the management of atrial fibrillation to prevent new clots from developing. However, neurologists face the challenge of when to initiate/reintroduce treatment after a recent episode of stroke without increasing haemorrhagic risk, especially if the st...
Autores principales: | Aghetti, Agnes, Reiner, Peggy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007060/ https://www.ncbi.nlm.nih.gov/pubmed/35462640 http://dx.doi.org/10.7573/dic.2021-10-5 |
Ejemplares similares
-
Tozinameran: Cardioembolic stroke: case report
Publicado: (2022) -
Acute Cardioembolic Stroke in the Setting of Subtherapeutic Anticoagulation
por: Ambatipudi, Ankit, et al.
Publicado: (2023) -
Cardioembolic stroke with hemorrhagic transformation in atrial fibrillation patients on anticoagulant therapy: A case report
por: Wulandari, Wulandari, et al.
Publicado: (2023) -
Acute ischaemic stroke attributed to multiple atrial cardioembolic sources
por: Takafuji, Hiroya, et al.
Publicado: (2023) -
Is Anticoagulation Necessary for Severely Disabled Cardioembolic Stroke Survivors?
por: Jurjans, Kristaps, et al.
Publicado: (2019)